about
Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.Clinical and biochemical characteristics of patients with home enteral nutrition in an area of Spain.Surgical infection and malnutrition.Gene expression analysis identify a metabolic and cell function alterations as a hallmark of obesity without metabolic syndrome in peripheral blood, a pilot study.Priming effect of benthic gastropod mucus on sedimentary organic matter remineralization.Relation of Trp64Arg polymorphism of beta3-adrenoreceptor gene with cardiovascular risk factors in presurgical morbidly obese patients.MEDITERRANEAN DIET IS ASSOCIATED WITH LIVER HISTOLOGY IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE.Effects of a high-protein/low-carbohydrate versus a standard hypocaloric diet on adipocytokine levels and cardiovascular risk factors during 9 months, role of rs6923761 gene variant of glucagon-like peptide 1 receptor.Effect of -55CT Polymorphism of UCP3 on Insulin Resistance and Cardiovascular Risk Factors after a High Protein/Low Carbohydrate versus a Standard Hypocaloric Diet.Association of G1359A polymorphism of the cannabinoid receptor gene (CNR1) with macronutrient intakes in obese females.Role of G308 promoter variant of tumor necrosis factor alpha gene on weight loss and metabolic parameters after a high monounsaturated versus a high polyunsaturated fat hypocaloric diets.Influence of G308A polymorphism of tumor necrosis factor alpha gene on surgical results of biliopancreatic diversion.Tissue electric properties in head and neck cancer patients.Circulating adipocytokines in obese nondiabetic patients in relationship with cardiovascular risk factors, anthropometry and resting-energy expenditure.Relation of resistin levels with cardiovascular risk factors, insulin resistance and inflammation in naïve diabetes obese patients.Influence of lys656asn polymorphism of leptin receptor gene on surgical results of biliopancreatic diversion.Effects of C358A missense polymorphism of the degrading enzyme fatty acid amide hydrolase on weight loss, adipocytokines, and insulin resistance after 2 hypocaloric diets.The effect of liver transplantation on circulating levels of estradiol and progesterone in male patients: parallelism with hepatopulmonary syndrome and systemic hyperdynamic circulation improvement.Influence of hormonal status and oral intake on phase angle in HIV-infected men.Relation of the rs9939609 gene variant in FTO with metabolic syndrome in obese female patients.Cardiovascular risk factors and adipocytokines levels after two hypocaloric diets with different fat distribution in obese subjects and rs6923761 gene variant of glucagon-like peptide 1 receptor.[Gene expression profiling in the first twelve weeks of treatment in chronic hepatitis C patients].Effect of rs6923761 gene variant of glucagon-like peptide 1 receptor on metabolic response and weight loss after a 3-month intervention with a hypocaloric diet.Postsurgery enteral nutrition in head and neck cancer patients.Relation between total homocysteine levels and beer intake in patients with diabetes mellitus Type 2.Genetic variation in the beta 3-adrenoreceptor gene (Trp64Arg polymorphism) and its influence on anthropometric parameters and insulin resistance under a high monounsaturated versus a high polyunsaturated fat hypocaloric diet.Pravastatin in hyperlipidemia secondary to HIV protease inhibitors without response to fenofibrate: a brief preliminary report.[Usefulness of miglitol in patients with diabetes mellitus type 2 and insufficient control of the blood glucose]Lack of association of serum resistin levels with metabolic syndrome criteria in obese female patients.Randomized clinical trial with an enteral arginine-enhanced formula in early postsurgical head and neck cancer patients.Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.Genetic variation in the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and their influence on weight loss and insulin resistance under a high monounsaturated fat hypocaloric diet.Clinical effects of a w3 enhanced powdered nutritional formula in postsurgical ambulatory head and neck cancer patients.Genetic variation in the cannabinoid receptor gene (CNR1) (G1359A polymorphism) and their influence on anthropometric parameters and metabolic parameters under a high monounsaturated vs. high polyunsaturated fat hypocaloric diets.Double blind randomized clinical trial controlled by placebo with a fos enriched cookie on saciety and cardiovascular risk factors in obese patients.Ala54Thr polymorphism of fatty acid binding protein 2, role on insulin resistance and cardiovascular risk factors in presurgical morbid obesity patients.Relation of the rs6923761 gene variant in glucagon-like peptide 1 receptor with weight, cardiovascular risk factor, and serum adipokine levels in obese female subjects.Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients.[The effects of a low-fat versus a low carbohydrate diet in obese adults].
P50
Q33346721-6583A361-F7AE-4918-8976-5915F992E065Q34632636-815D829A-CCF2-4D8E-8683-509D05482879Q35109692-DC5F6D35-FDC0-47A5-A2AF-084C359A51CDQ38252665-C228016E-C0A9-4C9B-B573-716B4FC0AAFFQ38716645-6C580E5E-0A5E-4738-BFFC-FB74EDD990B8Q39314832-321501B2-913E-4661-97F3-FAA9059772CBQ40029025-984B7D3C-3ED2-41A0-B1AB-F83629B21B38Q40211761-4ED2A0CA-AC58-4922-9A5E-CF268DC2C0F5Q40898644-718E5E8B-F9D7-490B-8311-E5D127D7C819Q40927874-81975E22-DDA6-4EA2-BFC5-AB2779499F0BQ41459812-F40D776D-4E9B-4304-BCD5-A5E3AC807EF1Q42437459-B13CCBEF-1B68-46F4-A08E-B5CD9BDC6FF4Q42437641-BF358361-2ADC-4AEF-A85F-86C13CB971AFQ42486202-7B7CBFCE-DD99-4CA1-A57B-4D87D91416F0Q42521632-1F8ACADD-519D-4EAF-9A1F-E5188D032BCCQ43088516-40F800E2-1A4B-463D-BF75-0544B4DDFAE5Q43137876-4CF6DCF4-E809-4909-B0C5-92785EC0182EQ43183758-94B3BE92-841C-41CD-902C-9261380B2265Q43709437-CE828A8D-CB59-4581-9DAE-9E6B82822135Q43734334-5E5D72BC-5BBE-4BE6-BC96-DFC0B610CBCFQ43756975-F06A4A9E-A1E4-4C53-B376-46A77F81F50AQ43765775-D106F7BE-2401-4F98-8C43-7DF6F4D79B4EQ44122716-7444D486-E12F-4409-B734-0CEC57C50E43Q44154687-DF83DA60-B214-44E8-979C-DC85809A3E59Q44213800-C0884C18-3175-4BCF-B77B-A854F66CE8F1Q44438736-91EA5166-405B-44E0-9607-24EFE494CC40Q44511893-1148ACF3-5272-4DD8-84A9-FFCF8431B429Q44618019-DBBFC5ED-559B-4493-B109-52F777B54240Q44744638-503133AD-3C65-415C-8ACA-FC77B62E38FFQ44849743-36DC97EA-A412-4EBE-A75C-78658E499FEEQ44892594-937A30AB-18DB-4AF5-B487-81340CBCEB0BQ45218550-6B28C7A3-BBB9-4182-AE70-7C4AF94FBA4AQ45395332-29AEBF26-E520-40C1-B873-B128FD546800Q45758936-8989F423-ABAC-4D13-9183-A66974031D70Q45818807-E0B05864-5AA3-4E28-9833-38FF112E69F3Q45930291-3D6D37B9-01C4-42EA-89F6-2EC12AAB049CQ45993266-417C3596-B131-4987-A671-6825C5BF4D72Q46065648-6D9A1E79-589E-4CD0-8428-F0555EBA1765Q46108914-D5CBD6B2-787C-43CD-998B-8BE44C8737D5Q46112353-891ECFFA-E758-45BD-9ECE-79F3A32B29F8
P50
description
researcher
@en
wetenschapper
@nl
name
Aller R
@nl
Rocio Aller
@en
type
label
Aller R
@nl
Rocio Aller
@en
altLabel
ROCIO ALLER DE LA FUENTE
@en
prefLabel
Aller R
@nl
Rocio Aller
@en
P106
P31
P496
0000-0002-6795-4541